Tenax Therapeutics (TENX) Cost of Revenue (2010 - 2013)
Tenax Therapeutics' (TENX) quarterly Cost of Revenue came in at $26533.0 in Q2 2013, up 629.53% year-on-year from $3637.0 in Q2 2012, and up 1629.66% quarter-over-quarter from $1534.0 in Q1 2013.
Tenax Therapeutics (TENX) Cost of Revenue (2010 - 2013) Analysis & Trends
Tenax Therapeutics has disclosed Cost of Revenue across 4 years of filings, most recently posting $26533.0 for Q2 2013.
- Cost of Revenue for Q2 2013 came in at $26533.0, up 629.53% year-over-year; the trailing twelve-month figure through Dec 2015 was $37201.0 (changed N/A YoY), and the FY2014 annual result was $129800.0, up 201.08% from the prior year.
- Cost of Revenue came in at $26533.0 for Q2 2013 at Tenax Therapeutics, up from $1534.0 in the prior quarter.
- In the past five years, Cost of Revenue ranged from a high of $182464.0 in Q2 2011 to a low of $1534.0 in Q1 2013.
- The 4-year median for Cost of Revenue is $9045.5 (2010), against an average of $26129.1.
- Across the five-year window, Cost of Revenue surged 1833.18% in 2011 and slumped 98.01% in 2012, its largest moves.
- Tenax Therapeutics' Cost of Revenue stood at $8957.0 in 2010, then rose by 17.23% to $10500.0 in 2011, then decreased by 13.01% to $9134.0 in 2012, then jumped by 190.49% to $26533.0 in 2013.
- The last three Cost of Revenue figures came in at $26533.0 (Q2 2013), $1534.0 (Q1 2013), and $9134.0 (Q4 2012), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 64.20 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | 48,670.00 |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 392.80 Mn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | 2.05 Mn |
| 10 | Tenax Therapeutics | 120.33 Mn | 120.33 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2013 | 26,533.00 |
| Apr 30, 2013 | 26,533.00 |
| Jan 31, 2013 | 1,534.00 |
| Jan 31, 2013 | 1,534.00 |
| Oct 31, 2012 | 9,134.00 |
| Oct 31, 2012 | 9,134.00 |
| Jul 31, 2012 | 5,911.00 |
| Jul 31, 2012 | 5,911.00 |
| Apr 30, 2012 | 3,637.00 |
| Apr 30, 2012 | 3,637.00 |
| Jan 31, 2012 | 2,512.00 |
| Jan 31, 2012 | 2,512.00 |
| Oct 31, 2011 | 10,500.00 |
| Oct 31, 2011 | 10,500.00 |
| Jul 31, 2011 | 34,604.00 |
| Jul 31, 2011 | 34,604.00 |
| Apr 30, 2011 | 182,464.00 |
| Apr 30, 2011 | 182,464.00 |
| Jan 31, 2011 | 25,973.00 |
| Jan 31, 2011 | 25,973.00 |